MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BCRX made $874,837K in revenue. $262,978K in net income. Net profit margin of 30.06%.

Income Overview

Revenue
$874,837K
Net Income
$262,978K
Net Profit Margin
30.06%
EPS
$1.21
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License And Other Revenues
Revenue Breakdown
    • Product
    • License
    • Collaborative And Other Research...
Revenue Breakdown
    • Geographic Distribution Domestic
    • License
    • Geographic Distribution Foreign
    • Other Income From Contract With ...

Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Total revenues
874,837 450,712 331,412 270,827
Cost of product sales
19,075 12,269 4,481 6,408
Research and development
166,126 174,638 216,566 253,297
Selling, general and administrative
348,647 266,132 213,894 159,371
Royalty
-216 180 186
Total operating expenses
533,848 453,255 435,121 419,262
Income (loss) from operations
340,989 -2,543 -103,709 -148,435
Interest income
10,668 14,746 --
Interest and other income
--15,777 5,127
Interest expense
78,872 98,516 108,239 99,092
Foreign currency losses, net
-152 -641 -1,039 -1,983
Loss on extinguishment of debt
-17,332 0 -29,019 0
Other income
12,090 ---
Total other expense, net
-73,598 -84,411 --
Income (loss) before income taxes
267,391 -86,954 -226,229 -244,383
Income tax expense
3,530 1,927 310 2,733
Net income (loss)
263,861 -88,881 -226,539 -247,116
Foreign currency translation adjustment
-674 -776 180 890
Unrealized (loss) gain on available for sale investments
-209 360 --
Unrealized gain (loss) on available for sale investments
--1,131 -1,041
Total other comprehensive (loss) income
-883 -416 --
Net comprehensive income (loss)
262,978 -89,297 -225,228 -247,267
Basic EPS
1.26 -0.43 -1.18 -1.33
Diluted EPS
1.21 -0.43 -1.18 -1.33
Basic Average Shares
209,893,000 206,696,000 192,198,000 185,908,000
Diluted Average Shares
218,581,000 206,696,000 192,198,000 185,908,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product$623,151K (40.77%↑ Y/Y)License And OtherRevenues$251,686K Total revenues$874,837K (94.10%↑ Y/Y)Income (loss) fromoperations$340,989K (13508.93%↑ Y/Y)Total operatingexpenses$533,848K (17.78%↑ Y/Y)Income (loss) beforeincome taxes$267,391K (407.51%↑ Y/Y)Total other expense,net-$73,598K (12.81%↑ Y/Y)Other income$12,090K Selling, general andadministrative$348,647K (31.01%↑ Y/Y)Research and development$166,126K (-4.87%↓ Y/Y)Cost of product sales$19,075K (55.47%↑ Y/Y)Interest income$10,668K (-27.65%↓ Y/Y)Net income (loss)$263,861K (396.87%↑ Y/Y)Income tax expense$3,530K (83.19%↑ Y/Y)Interest expense$78,872K (-19.94%↓ Y/Y)Loss onextinguishment of debt-$17,332K Foreign currencylosses, net-$152K (76.29%↑ Y/Y)Net comprehensiveincome (loss)$262,978K (394.50%↑ Y/Y)Total othercomprehensive (loss) income-$883K (-112.26%↓ Y/Y)Foreign currencytranslation adjustment-$674K (13.14%↑ Y/Y)Unrealized (loss) gain onavailable for sale...-$209K (-158.06%↓ Y/Y)

BIOCRYST PHARMACEUTICALS INC (BCRX)

BIOCRYST PHARMACEUTICALS INC (BCRX)